HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A study of infusional port re-insertion in patients with liver metastasis].

Abstract
We evaluated the importance and usefulness of re-insertion of the intra-arterial infusion catheter in 10 patients with liver metastasis who showed problems in the catheter or system during intra-arterial infusion chemotherapy. The route of re-insertion was laparotomy-->left subclavian method in 3 patients, left subclavian-->left subclavian method in 5, and left subclavian-->femoral method in 2. The cause of re-insertion was dislocation in 5 patients, obstruction of the system in 4, and obstruction of CHA in 1. In the patients showing dislocation, re-insertion was performed after a mean of 4 months, and CEA improvement and direct effects evaluated by imaging techniques were marked, suggesting good indication. In the patients showing system obstruction or CHA obstruction, re-insertion was performed after a mean of 8.6 months, and CEA improvement and direct effects were less than those in the patients showing dislocation. Of the 10 patients who underwent re-insertion, 5 have survived to the present for 13-20 months (mean, 17 months). The prognosis of liver metastasis may be improved by active re-insertion of the intra-arterial infusion catheter.
AuthorsH Ishikawa, K Kajiwara, T Nishida, F Kubota, H Minami, N Itoyanagi, F Akama, S Narimatu, Y Nakamura, Y Ushimi
JournalGan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 20 Issue 11 Pg. 1499-502 (Aug 1993) ISSN: 0385-0684 [Print] Japan
PMID8373206 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Antineoplastic Agents
Topics
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents (administration & dosage)
  • Catheters, Indwelling
  • Colonic Neoplasms (pathology)
  • Equipment Failure
  • Female
  • Humans
  • Infusion Pumps, Implantable
  • Infusions, Intra-Arterial
  • Liver Neoplasms (drug therapy, secondary)
  • Male
  • Middle Aged
  • Prognosis
  • Stomach Neoplasms (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: